Results for: C_TS4CO_2023日本語出題内容 🐇 C_TS4CO_2023日本語全真模擬試験 🥗 C_TS4CO_2023日本語試験勉強書 🤟 ➡ www.goshiken.com ️⬅️で✔ C_TS4CO_2023日本語 ️✔️を検索して、無料で簡単にダウンロードできますC_TS4CO_2023日本語試験参考書

Diagnosing pathological Internet use

October 6, 2010

…; 8: 413-418; Young. J Contemp Psychother 2009; 39: 241-246) (For a recent comment from Canadian researchers see El-Guebaly & Mudry. World Psychiatry 2010; 9: 93-94; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC2911084/?tool=pubmed). Clinical data are lacking, but a Problematic Internet Use Questionnaire is currently in development (Thatcher & Goolam. S Afr J Psychol 2005; 35: 793-809). Subscribe to read more It takes 30 seconds or login…

ECT: Response and common side effects

September 29, 2010

…Report from the 163rd annual meeting of the American Psychiatric Association, New Orleans LA, May 22-26, 2010 – Two studies have examined the effectiveness and side effect profile of electroconvulsive therapy (ECT) in patients with mood disorders. Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…

Treatment of nonmotor symptoms: AAN report

September 1, 2010

The AAN Quality Standards subcommittee has issued its recommendations on the treatment of nonmotor symptoms in patients with Parkinson’s disease (Zesiewicz et al. Neurology 2010; 74: 924-931; free full text at www.neurology.org/cgi/reprint/74/11/924). Nonmotor symptoms addressed included sleep disorders (restless legs syndrome, periodic limb movements of sleep, excessive daytime somnolence, insomnia, REM sleep behaviour disorder), autonomic dysfu…

Treating late-life depression benefits caregivers

August 18, 2010

…A U.S. study reports that the beneficial effects of treating depression in older patients extend to caregivers (Martire et al. J Am Geriatr Soc 2010; 58: 23-29; free full text at www.ncbi.nlm.nih.gov/pmc/articles/PMC2872092/?tool=pubmed). Subscribe to read more It takes 30 seconds or login using your email address Please enter the email address that you registered the newsletter with Continue…

Mitoxantrone in MS: AAN report

August 18, 2010

The AAN Therapeutics and Technology Assessment subcommittee has published its report on the safety and efficacy of mitoxantrone in multiple sclerosis, concluding that the risks of systolic dysfunction and therapy-related leukemia are higher than previously estimated (Marriott et al. Neurology 2010; 74: 1463-1470; free full text at www.neurology.org/cgi/reprint/74/18/1463). Subscribe to read more It takes 30 seconds or login using your email addre…